6th April, 2024 – The financial guru from CNBC, Jim Cramer, had brought into the notice the rosy prospect of microcap stocks, particularly in healthcare as one of the best investment options for the year 2024. Stating that the most notable effect is the revival of the smaller companies, Cramer indicated five companies that though seem to be less known, still have the potential for great growth.
Among the listed companies is Integer Holdings, a popular medical-device manufacturer which is in the sector of product design. Cramer noted the company’s favorable standing due to the constant health-care occupation rates and the fact that there is a backlog of patient procedures that had been postponed during the pandemic.
Another stock that Cramer advises is Progyny, a fertility benefits management firm which is growing very fast but being ignored by stock investors. The company’s service provisions provide reproductive health support through businesses, which are increasingly becoming part of the benefits employers provide particularly during labor shortages.
The company Owens & Minor, recognised for its major role during the pandemic in producing personal protective gear, stood out to Cramer for its strategic mergers and great promise in the leading health-care utilization sector.
Catalyst Pharmaceuticals happened to be seen as promising by Cramer, in spite of his conventional wary stance towards biotech companies, due to its shift into rare diseases and new drug launches, which opened the door for growth for pharma.
Last but not the least, Cramer referred to Addus HomeCare as a worth noticing provider that is engaged in transporting healthcare to lower-cost sites including private home-based services such as daily assistance and hospice care.
Summarizing, Cramer suggests that the future of the health sector belongs to players that possess real solutions and offer room for growth within the environment that keeps witnessing explosive dynamics.
Author: Simona Merlo